ELIA, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 1.954
EU - Europa 414
AS - Asia 412
SA - Sud America 2
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.785
Nazione #
US - Stati Uniti d'America 1.952
CN - Cina 289
UA - Ucraina 168
IT - Italia 84
HK - Hong Kong 72
DE - Germania 40
SG - Singapore 38
IE - Irlanda 37
FI - Finlandia 28
GB - Regno Unito 21
FR - Francia 12
BE - Belgio 9
SE - Svezia 7
IN - India 5
KR - Corea 3
NL - Olanda 3
AR - Argentina 2
CA - Canada 2
GR - Grecia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CH - Svizzera 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
MU - Mauritius 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
Totale 2.785
Città #
Fairfield 340
Woodbridge 213
Houston 189
Ashburn 144
Cambridge 134
Jacksonville 133
Chandler 132
Seattle 121
Ann Arbor 119
Wilmington 83
Dearborn 73
Hong Kong 72
Princeton 68
Beijing 52
Nanjing 50
Dublin 37
Brescia 30
Helsinki 26
New York 26
Singapore 23
Jinan 21
Nanchang 18
Des Moines 17
San Diego 17
Hebei 15
Shenyang 15
Changsha 14
Shanghai 14
Jiaxing 12
Ningbo 11
Brussels 9
Lanzhou 8
London 8
Tianjin 8
Haikou 7
Isola Vicentina 7
Taizhou 7
Zhengzhou 6
Guangzhou 5
Hangzhou 5
Verona 5
Kunming 4
Milan 4
San Francisco 4
Fuzhou 3
Orange 3
Sarezzo 3
Desio 2
Hefei 2
Kilburn 2
Lappeenranta 2
Monza 2
Norwalk 2
Pune 2
Redmond 2
Toronto 2
Amsterdam 1
Atlanta 1
Baotou 1
Buenos Aires 1
Canberra 1
Chengdu 1
Chisinau 1
Chongqing 1
Como 1
Cosenza 1
Foshan 1
Groningen 1
Grossmuehlingen 1
Gunzenhausen 1
Hounslow 1
Kocaeli 1
Los Angeles 1
Marseille 1
Mountain View 1
Nanning 1
Nuvolera 1
Orzivecchi 1
Paris 1
Redwood City 1
Riyadh 1
Rockville 1
Rome 1
Seoul 1
Taiyuan 1
Tokyo 1
Walnut 1
Wandsworth 1
Washington 1
Totale 2.366
Nome #
Epigenetics and vascular diseases 127
Ferritin, cellular iron storage and regulation 124
T cell costimulation blockade blunts pressure overload-induced heart failure 117
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 112
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications 110
Circular RNAs and heart failure: new players for an old disease 108
MicroRNA 143-145 deficiency impairs vascular function 108
Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment 106
MicroRNA-133 controls cardiac hypertrophy 106
Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: Initial identification of predictive biomarkers 105
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease 104
A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion 104
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection 101
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro 98
RNA (Epi)genetics in cardiovascular diseases 97
MicroRNAs and pulmonary hypertension: A tight link 96
Arterial remodeling and atherosclerosis: MiRNAs involvement 96
CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge 96
MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines 95
The involvement of epigenetics in vascular disease development 95
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects 91
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 88
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 88
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice 87
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 67
MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade 62
miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases 60
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 38
Frailty and cognitive impairment in elderly patients: miRNAs as new biomarkers (MATCH-In project) 35
The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell–monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway 33
microRNAs as possible biomarkers of frailty and cognitive impairment: the MATCH-In project 27
rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk 23
microRNAs as new biomarkers in frailty associated with cognitive impairment in elderly patients (MATCH-In project) 22
Aggravation of pulmonary fibrosis after knocking down the Aryl hydrocarbon receptor in the Insulin-like growth factor 1 receptor pathway 20
Vascular malformation rupture in a patient affected by Costello syndrome 11
Epigenetics and Vascular Disease 9
Editorial: Emerging roles of miRNAs in cardiovascular disease 7
The role of epigenetics in cardiovascular disease 5
A New Molecular Axis to Tackle the Development of Abdominal Aortic Aneurysm 2
Totale 2.880
Categoria #
all - tutte 14.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020952 107 21 30 93 57 127 135 92 73 142 31 44
2020/2021440 10 61 19 46 29 38 16 51 43 58 53 16
2021/2022331 29 54 20 13 2 7 33 21 22 41 22 67
2022/2023318 55 0 2 30 34 81 2 42 48 7 9 8
2023/2024238 16 4 14 25 7 33 7 9 79 1 3 40
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 2.880